European Union starts COVID-19 vaccination program
European Union nations, including France, Germany, Italy, Austria, the Czech Republic, Bulgaria, Greece, Latvia, Portugal and Spain have commenced mass
Read more
Latest
UK could approve AstraZeneca’s COVID-19 vaccine as early as next week
The United Kingdom could approve AstraZeneca’s COVID-19 vaccine as early as next week as the British-swedish pharmaceutical company seems to
Read more
Moderna’s COVID-19 vaccine approved by the FDA for emergency use
The U.S. FDA has approved Moderna’s COVID-19 vaccine for emergency use. Moderna’s vaccine becomes the second to be approved by
Read more
US FDA clears Pfizer-BioNTech COVID-19 Vaccine for emergency use
The United States FDA has approved the emergency use of Pfizer and BioNTech’s COVID-19 vaccine on Friday, paving the way
Read more
Roche teams up with Moderna to add antibody test in COVID-19 vaccine trials
Roche revealed a new collaboration agreement with Moderna to use the Elecsys® Anti-SARS-CoV-2 S antibody assay in Moderna’s COVID-19 vaccine
Read more
UK approves Pfizer and BioNTech’s COVID-19 vaccine for emergency use
The UK has become the first western country to approve Pfizer and BioNTech’s COVID-19 vaccine for emergency use. The United
Read more
FDA approves Roche’s Xofluza for Influenza post-exposure prophylaxis
Roche has announced that the U.S. FDA has granted supplemental New Drug Application (sNDA) approval for Xofluza, the first single-dose
Read more
EC to purchase up to 160 mill doses of Moderna’s COVID-19 vaccine
Moderna announced today that the European Commission has approved an agreement to buy 80 million doses of mRNA-1273, Moderna’s COVID-19
Read more
Trial data shows AstraZeneca’s COVID-19 vaccine was highly effective
AstraZeneca announced today, that interim trial data has shown it’s COVID-19 vaccine candidate AZD1222, developed in collaboration with the University
Read more
Moderna’s COVID-19 vaccine shows efficacy of 94.5% in Phase 3 trial
Moderna announced its vaccine candidate against COVID-19 named mRNA-1273, has met Phase 3 study statistical criteria with a vaccine efficacy
Read more